Tapewire

NYSE · USD

MET

METLIFE INC

Export transactions ↓
Tapewire entity
488
SEC CIK
0001099219
Parsed reports
1,091

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 25, 2020 Filed Feb 27, 2020 23:44 UTC
Lee EstherEVP - Gl. Chief Marketing Off.
GrantRestricted Stock Units · Derivative 3,941 $0.00 $0.00
Disclosure

SEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · derivative · entry 4

Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,941

Underlying: Common Stock · 3,941 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock.

F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:44 UTC
Lee EstherEVP - Gl. Chief Marketing Off.
GrantEmployee Stock Options (right to buy) · Derivative 11,823 $0.00 Strike: $47.58 $0.00
Disclosure

SEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · derivative · entry 3

Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,823

Underlying: Common Stock · 11,823 shares

Expires 2030-02-24

F3 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:44 UTC
Lee EstherEVP - Gl. Chief Marketing Off.
Tax withholdingCommon Stock 249 $47.58 $11,847.42
Disclosure

SEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · nonDerivative · entry 2

Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,446

F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the deferred shares.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:44 UTC
Lee EstherEVP - Gl. Chief Marketing Off.
GrantCommon Stock 9,755 Not disclosed Not disclosed
Disclosure

SEC source: 0001099219-20-000093 · wf-form4_158284702473671.xml · nonDerivative · entry 1

Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,695

F1 · price: Shares earned from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. The reporting person deferred these shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such shares for a specific period of time.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:43 UTC
Goulart Steven JEVP & Chief Investment Officer
GrantRestricted Stock Units · Derivative 12,611 $0.00 $0.00
Disclosure

SEC source: 0001099219-20-000092 · wf-form4_158284700404502.xml · derivative · entry 4

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,611

Underlying: Common Stock · 12,611 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock.

F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:43 UTC
Goulart Steven JEVP & Chief Investment Officer
GrantEmployee Stock Options (right to buy) · Derivative 37,832 $0.00 Strike: $47.58 $0.00
Disclosure

SEC source: 0001099219-20-000092 · wf-form4_158284700404502.xml · derivative · entry 3

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,832

Underlying: Common Stock · 37,832 shares

Expires 2030-02-24

F3 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:43 UTC
Goulart Steven JEVP & Chief Investment Officer
Tax withholdingCommon Stock 10,095 $47.58 $480,320.10
Disclosure

SEC source: 0001099219-20-000092 · wf-form4_158284700404502.xml · nonDerivative · entry 2

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,222

F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:43 UTC
Goulart Steven JEVP & Chief Investment Officer
GrantCommon Stock 24,387 Not disclosed Not disclosed
Disclosure

SEC source: 0001099219-20-000092 · wf-form4_158284700404502.xml · nonDerivative · entry 1

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,317

F1 · price: Shares acquired from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:43 UTC
GAUSTER STEPHEN WEVP & General Counsel
GrantRestricted Stock Units · Derivative 4,256 $0.00 $0.00
Disclosure

SEC source: 0001099219-20-000091 · wf-form4_158284698252435.xml · derivative · entry 4

GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,256

Underlying: Common Stock · 4,256 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock.

F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:43 UTC
GAUSTER STEPHEN WEVP & General Counsel
GrantEmployee Stock Options (right to buy) · Derivative 12,768 $0.00 Strike: $47.58 $0.00
Disclosure

SEC source: 0001099219-20-000091 · wf-form4_158284698252435.xml · derivative · entry 3

GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,768

Underlying: Common Stock · 12,768 shares

Expires 2030-02-24

F3 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:43 UTC
GAUSTER STEPHEN WEVP & General Counsel
Tax withholdingCommon Stock 1,219 $47.58 $58,000.02
Disclosure

SEC source: 0001099219-20-000091 · wf-form4_158284698252435.xml · nonDerivative · entry 2

GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,382

F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:43 UTC
GAUSTER STEPHEN WEVP & General Counsel
GrantCommon Stock 3,122 Not disclosed Not disclosed
Disclosure

SEC source: 0001099219-20-000091 · wf-form4_158284698252435.xml · nonDerivative · entry 1

GAUSTER STEPHEN W · CIK 0001709219 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,601

F1 · price: Shares acquired from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:41 UTC
Khalaf MichelDirector · President & CEO
GrantRestricted Stock Units · Derivative 31,526 $0.00 $0.00
Disclosure

SEC source: 0001099219-20-000089 · wf-form4_158284688023809.xml · derivative · entry 4

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,526

Underlying: Common Stock · 31,526 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock.

F4 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

F4 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:41 UTC
Khalaf MichelDirector · President & CEO
GrantEmployee Stock Options (right to buy) · Derivative 94,578 $0.00 Strike: $47.58 $0.00
Disclosure

SEC source: 0001099219-20-000089 · wf-form4_158284688023809.xml · derivative · entry 3

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,578

Underlying: Common Stock · 94,578 shares

Expires 2030-02-24

F2 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:41 UTC
Khalaf MichelDirector · President & CEO
Disposition to issuerCommon Stock 17,558 $47.58 $835,409.64
Disclosure

SEC source: 0001099219-20-000089 · wf-form4_158284688023809.xml · nonDerivative · entry 2

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,580

F1 · kind: Cash payout of 2017-2019 performance units, following determination of the performance factor for such award. Each performance unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:41 UTC
Khalaf MichelDirector · President & CEO
GrantCommon Stock 17,558 Not disclosed Not disclosed
Disclosure

SEC source: 0001099219-20-000089 · wf-form4_158284688023809.xml · nonDerivative · entry 1

Khalaf Michel · CIK 0001535491 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,138

F1 · price: Cash payout of 2017-2019 performance units, following determination of the performance factor for such award. Each performance unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:42 UTC
DEBEL MARLENEEVP & Chief Risk Officer
GrantRestricted Stock Units · Derivative 4,414 $0.00 $0.00
Disclosure

SEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · derivative · entry 4

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,414

Underlying: Common Stock · 4,414 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock.

F5 · derivative.exercise_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

F5 · derivative.expiration_date: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:42 UTC
DEBEL MARLENEEVP & Chief Risk Officer
GrantEmployee Stock Options (right to buy) · Derivative 13,241 $0.00 Strike: $47.58 $0.00
Disclosure

SEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · derivative · entry 3

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,241

Underlying: Common Stock · 13,241 shares

Expires 2030-02-24

F3 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:42 UTC
DEBEL MARLENEEVP & Chief Risk Officer
Tax withholdingCommon Stock 2,221 $47.58 $105,675.18
Disclosure

SEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · nonDerivative · entry 2

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,322

F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 23:42 UTC
DEBEL MARLENEEVP & Chief Risk Officer
GrantCommon Stock 6,458 Not disclosed Not disclosed
Disclosure

SEC source: 0001099219-20-000090 · wf-form4_158284695583245.xml · nonDerivative · entry 1

DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,543

F1 · price: Shares acquired from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

Read SEC document
February 10, 2020 Filed Feb 13, 2020 00:17 UTC
Goulart Steven JEVP & Chief Investment Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 19,141 $0.00 Strike: $31.13 $0.00
Disclosure

SEC source: 0001099219-20-000055 · wf-form4_158155303145185.xml · derivative · entry 3

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,141 shares

Expires 2020-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2011, 2012 and 2013.

Read SEC document
February 10, 2020 Filed Feb 13, 2020 00:17 UTC
Goulart Steven JEVP & Chief Investment Officer
SaleCommon Stock 14,200 $51.60 $732,649.00
Disclosure

SEC source: 0001099219-20-000055 · wf-form4_158155303145185.xml · nonDerivative · entry 2

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,930

F1 · shares: The Reporting Person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on February 10, 2020 and related tax obligations and fees.

Read SEC document
February 10, 2020 Filed Feb 13, 2020 00:17 UTC
Goulart Steven JEVP & Chief Investment Officer
Exercise / conversionCommon Stock 19,141 $31.13 $595,859.33
Disclosure

SEC source: 0001099219-20-000055 · wf-form4_158155303145185.xml · nonDerivative · entry 1

Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2020 Filed Feb 13, 2020 00:17 UTC
SCHMIDT OSCARPresident, Latin America
Exercise / conversionUnit Options (Cash-Payable) · Derivative 30,558 $0.00 Strike: $40.91 $0.00
Disclosure

SEC source: 0001099219-20-000056 · wf-form4_158155305494390.xml · derivative · entry 3

SCHMIDT OSCAR · CIK 0001738204 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,558 shares

Expires 2021-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The unit options became exercisable in three equal installments on February 23, 2012, 2013 and 2014.

Read SEC document
February 10, 2020 Filed Feb 13, 2020 00:17 UTC
SCHMIDT OSCARPresident, Latin America
Disposition to issuerCommon Stock 30,558 $51.66 $1,578,595.72
Disclosure

SEC source: 0001099219-20-000056 · wf-form4_158155305494390.xml · nonDerivative · entry 2

SCHMIDT OSCAR · CIK 0001738204 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Exercise of unit options, which are cash-payable stock appreciation rights.

Read SEC document
February 10, 2020 Filed Feb 13, 2020 00:17 UTC
SCHMIDT OSCARPresident, Latin America
Exercise / conversionCommon Stock 30,558 $40.91 $1,250,127.78
Disclosure

SEC source: 0001099219-20-000056 · wf-form4_158155305494390.xml · nonDerivative · entry 1

SCHMIDT OSCAR · CIK 0001738204 · President, Latin America

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of unit options, which are cash-payable stock appreciation rights.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:49 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000042 · wf-form4_157834736962384.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,554

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:50 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000045 · wf-form4_157834743659746.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,777

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:51 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000048 · wf-form4_157834749967861.xml · nonDerivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,786

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:51 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000047 · wf-form4_157834747874883.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,696

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:51 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000046 · wf-form4_157834745741825.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,579

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:50 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000043 · wf-form4_157834739107436.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,484

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:50 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000044 · wf-form4_157834741534870.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,669

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:49 UTC GrantCommon Stock 1,332 $51.62 $68,757.84
Disclosure

SEC source: 0001099219-20-000041 · wf-form4_157834734668706.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,182

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees and 50% of Board Chair retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:49 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000040 · wf-form4_157834732576594.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,908

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:48 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000038 · wf-form4_157834728107694.xml · nonDerivative · entry 1

GUTIERREZ CARLOS M · CIK 0001185943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,730

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:48 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000039 · wf-form4_157834730240030.xml · nonDerivative · entry 1

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,930

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 21:47 UTC GrantCommon Stock 727 $51.62 $37,527.74
Disclosure

SEC source: 0001099219-20-000037 · wf-form4_157834725674088.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,300

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
December 23, 2019 Filed Dec 26, 2019 21:19 UTC
McCallion John D.EVP & Chief Financial Officer
Exercise / conversionEmployee Stock Options (right to buy) · Derivative 6,716 $0.00 Strike: $31.13 $0.00
Disclosure

SEC source: 0001099219-19-000270 · wf-form4_157739517975205.xml · derivative · entry 3

McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,716 shares

Expires 2020-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 23, 2011, 2012 and 2013.

Read SEC document
December 23, 2019 Filed Dec 26, 2019 21:19 UTC
McCallion John D.EVP & Chief Financial Officer
SaleCommon Stock 5,378 $51.17 $275,176.13
Disclosure

SEC source: 0001099219-19-000270 · wf-form4_157739517975205.xml · nonDerivative · entry 2

McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,263

F1 · shares: The Reporting Person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 23, 2019 and related tax obligations and fees.

Read SEC document
December 23, 2019 Filed Dec 26, 2019 21:19 UTC
McCallion John D.EVP & Chief Financial Officer
Exercise / conversionCommon Stock 6,716 $31.13 $209,069.08
Disclosure

SEC source: 0001099219-19-000270 · wf-form4_157739517975205.xml · nonDerivative · entry 1

McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2019 Filed Dec 17, 2019 22:00 UTC OtherDeferred Share Equivalents · Derivative 11,917 $50.48 $601,570.16
Disclosure

SEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · derivative · entry 4

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,917 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F5 · kind: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities.

F5 · price: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities.

F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 16, 2019 Filed Dec 17, 2019 21:53 UTC OtherDeferred Share Equivalents · Derivative 24,485 $50.48 $1,236,002.80
Disclosure

SEC source: 0001099219-19-000255 · wf-form4_157661956722583.xml · derivative · entry 3

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,485 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities.

F4 · price: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 16, 2019 Filed Dec 17, 2019 21:47 UTC OtherDeferred Share Equivalents · Derivative 2,469 $50.48 $124,635.12
Disclosure

SEC source: 0001099219-19-000251 · wf-form4_157661921710346.xml · derivative · entry 3

HASSELL GERALD L · CIK 0001209482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,469 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities.

F4 · price: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities.

F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 22:10 UTC GrantCommon Stock 33 $50.38 $1,662.54
Disclosure

SEC source: 0001099219-19-000267 · wf-form4_157662060261576.xml · nonDerivative · entry 1

MCKENZIE DIANA · CIK 0001754648 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,852

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 22:07 UTC
Lee EstherEVP & Chief Marketing Officer
GrantCommon Stock 111 $50.38 $5,592.18
Disclosure

SEC source: 0001099219-19-000265 · wf-form4_157662041646747.xml · nonDerivative · entry 1

Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,940

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 22:00 UTC GrantDeferred Share Equivalents · Derivative 103 $50.38 $5,189.14
Disclosure

SEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · derivative · entry 3

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,917

Underlying: Common Stock · 103 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F4 · timeliness: Represents imputed reinvestment of dividends on Deferred Share Equivalents.

F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 22:00 UTC GrantCommon Stock 485 $50.38 $24,434.30
Disclosure

SEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,942

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 22:04 UTC GrantCommon Stock 274 $50.38 $13,804.12
Disclosure

SEC source: 0001099219-19-000263 · wf-form4_157662024285925.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,050

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:57 UTC GrantCommon Stock 188 $50.38 $9,471.44
Disclosure

SEC source: 0001099219-19-000259 · wf-form4_157661985493355.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,757

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.